MedWatch

New US monkeypox vaccine order prompts Bavarian Nordic upgrade

The US authorities have placed an order for an additional 2.5 million doses of Jynneos, the world’s only approved vaccine in the monkeypox indication.

Photo: Philip Davali/Ekstra Bladet, Philip Davali

On Friday, the US Biomedical Advanced Research and Development Authority (BARDA) placed an order for an additional 2.5 million doses of Jynneos, reported Danish vaccine maker Bavarian Nordic in a press release.

Based on this new and other recent vaccine orders, Bavarian Nordic has upgraded its financial expectations for 2022.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs